Cormorant Asset Management’s DexCom DXCM Stock Holding History

Cormorant Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-280,000	Closed	-$5.12M	–	57
2017 Q2	$5.12M	Hold	280,000	–	–	0.85%	31
2017 Q1	$5.93M	Sell	280,000 -80,000	-22%	-$1.56M	0.86%	37
2016 Q4	$5.37M	Sell	360,000 -40,000	-10%	-$709K	0.72%	39
2016 Q3	$8.77M	Hold	400,000	–	–	0.97%	34
2016 Q2	$7.93M	Sell	400,000 -212,000	-35%	-$3.61M	1.13%	32
2016 Q1	$10.4M	Hold	612,000	–	–	1.57%	26
2015 Q4	$12.5M	Hold	612,000	–	–	1.5%	25
2015 Q3	$13.1M	Hold	612,000	–	–	2.1%	13
2015 Q2	$12.2M	Hold	612,000	–	–	1.63%	19
2015 Q1	$9.54M	Sell	612,000 -188,000	-24%	-$2.84M	1.47%	19
2014 Q4	$11M	Hold	800,000	–	–	1.7%	20
2014 Q3	$8M	Hold	800,000	–	–	1.65%	14
2014 Q2	$7.93M	Sell	800,000 -400,000	-33%	-$3.54M	2.1%	15
2014 Q1	$12.4M	Hold	1,200,000	–	–	2.85%	13
2013 Q4	$10.6M	Buy	+1,200,000	New	+$9.5M	3.08%	13

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cormorant Asset Management's DXCM Position: Q3 2017 in Review

Cormorant Asset Management sold out of DexCom (DXCM) in Q3 2017, closing a stake of 280,000 shares — an estimated $5.12M sold.

Cormorant Asset Management first reported a position in DXCM in Q4 2013 and held it in 15 quarters. The position peaked at $13.1M in Q3 2015. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

Cormorant Asset Management reported no remaining DexCom position as of Q3 2017 after selling out during the quarter.
Cormorant Asset Management sold 280,000 DexCom shares in Q3 2017, an estimated $5.12M.
Cormorant Asset Management first reported a position in DexCom in Q4 2013 and held it in 15 quarters.
Cormorant Asset Management's DexCom position peaked at $13.1M in Q3 2015.
275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on Cormorant Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.